<![CDATA[High Potential Start-Ups]]>Mon, 16 Jan 2023 14:52:51 +0000Captivate.fmNick Taylorhttps://artwork.captivate.fm/3f741839-79f3-4514-a956-c609cf1d8a89/OgL3XxtiB_WpJisS8pAExhky.pngHigh Potential Start-UpsNick TaylorNick TaylorWe’ll learn from life science leaders about the groundbreaking work they’re involved with, and the journey they’ve taken to get to where they are in their career today - what motivates them, how they made it to the C suite in the first place, what it takes to stay there, and where they plan to go next. Guests are positioned as expert minds on compelling missions. The chance to align with personalities and brands on a similar journey is a major draw for talent in today’s busy marketplace. An appearance on the podcast serves as a priceless piece of branding collateral that employers can guarantee represents their message faithfully. Moreover, the podcast affords our guests a platform to draw international attention to the work their organisation is doing, introducing their brand to a global audience of potential investors in the process.https://high-potential-start-ups.captivate.fmnoepisodicEmil Pot, Co-Founder and CEO of Allero TherapeuticsEmil Pot, Co-Founder and CEO of Allero TherapeuticsAs something that affects as much as 10% of the global population, food allergies are an important topic of discussion in this value-packed episode of High Potential Start-ups.

In episode 3, guest speaker Emil Pot, Co-Founder and CEO of Allero Therapeutics, and host Nick Ross, Co-Founder of Cavenagh Health, delve into numerous talking points surrounding everything from food-related immune disorders to running a successful biotech company. 

Emil’s career started in law, but his keen interest in science quickly led to biotech becoming the central point of his career.

Now, Emil and his team at Allero Therapeutics have developed an innovative solution to treating autoimmune disorders like celiac disease.

Get in touch with Emil.

Get in Touch with Nick.

]]>As something that affects as much as 10% of the global population, food allergies are an important topic of discussion in this value-packed episode of High Potential Start-ups.

In episode 3, guest speaker Emil Pot, Co-Founder and CEO of Allero Therapeutics, and host Nick Ross, Co-Founder of Cavenagh Health, delve into numerous talking points surrounding everything from food-related immune disorders to running a successful biotech company. 

Emil’s career started in law, but his keen interest in science quickly led to biotech becoming the central point of his career.

Now, Emil and his team at Allero Therapeutics have developed an innovative solution to treating autoimmune disorders like celiac disease.

Get in touch with Emil.

Get in Touch with Nick.

]]>2d17b3f5-7103-4390-87ac-2d6bb02ad186Wed, 20 Oct 2021 09:00:00 +000049:15nofull13Nick TaylorJoão Seixas, CEO of TargTexJoão Seixas, CEO of TargTexIn episode 2 of the High Potential Start-Ups podcast, we’re joined by CEO of TargTex, João Seixas. 

João has a great ambition and an incredible passion for the treatment of brain cancer, and it’s woven through the operations of the business. During this insightful conversation, João details his career, from his journey from academia to business, what he picked up from each step of his career, and how that molded him into the leader that he is today. 

João always felt that the world of academics and research were very comfortable and familiar territories, and he moved into industry because he wanted to challenge himself scientifically. That led him to TargTex, a business with a big vision - to help increase the life expectancy of neuro-oncology patients. 

In this episode, you’ll find out how to take health from the lab to industry, and get so many more golden nuggets from João.

]]>In episode 2 of the High Potential Start-Ups podcast, we’re joined by CEO of TargTex, João Seixas. 

João has a great ambition and an incredible passion for the treatment of brain cancer, and it’s woven through the operations of the business. During this insightful conversation, João details his career, from his journey from academia to business, what he picked up from each step of his career, and how that molded him into the leader that he is today. 

João always felt that the world of academics and research were very comfortable and familiar territories, and he moved into industry because he wanted to challenge himself scientifically. That led him to TargTex, a business with a big vision - to help increase the life expectancy of neuro-oncology patients. 

In this episode, you’ll find out how to take health from the lab to industry, and get so many more golden nuggets from João.

]]>7cc2b1a2-07f6-4309-82d3-51329df7c8f7Tue, 05 Oct 2021 08:00:00 +000044:01nofull12Nick TaylorShardi Nahavandi, CEO & Co-founder at TuuneShardi Nahavandi, CEO & Co-founder at TuuneWelcome to High-Potential Start-Ups, season 1, episode 1!

In this episode, Nick Ross, co-founder of Cavenagh Health, is joined by Shardi Nahavandi, CEO and Co-founder at Tuune. 

During this inspiring conversation, Shardi reveals the personal story behind starting Tuune, why she hires for mindset over skillset, and why Tuune is fundamentally a learning company. 

Interestingly, Shardi started her career in sustainable architecture but after becoming jaded with the industry, she decided to change her career path to health tech. During her studies, however, she struggled to get treatment for a health issue. Combining this struggle with her self proclaimed “allergic reaction to justice” led to the birth of Tuune. 

Alongside this story, this episode is packed with insight into start-up life in the health tech space.

]]>Welcome to High-Potential Start-Ups, season 1, episode 1!

In this episode, Nick Ross, co-founder of Cavenagh Health, is joined by Shardi Nahavandi, CEO and Co-founder at Tuune. 

During this inspiring conversation, Shardi reveals the personal story behind starting Tuune, why she hires for mindset over skillset, and why Tuune is fundamentally a learning company. 

Interestingly, Shardi started her career in sustainable architecture but after becoming jaded with the industry, she decided to change her career path to health tech. During her studies, however, she struggled to get treatment for a health issue. Combining this struggle with her self proclaimed “allergic reaction to justice” led to the birth of Tuune. 

Alongside this story, this episode is packed with insight into start-up life in the health tech space.

]]>2075011d-f18b-4ca8-b686-04b3ca03c720Mon, 20 Sep 2021 15:30:00 +000050:26nofull11During this inspiring conversation, Shardi reveals the personal story behind starting Tuune, why she hires for mindset over skillset, and why Tuune is fundamentally a learning company.Nick Taylor